As of 2026-03-26, the Relative Valuation of Virbac SA (VIRP.PA) is 1,241.52 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 354.50 EUR, the upside of Virbac SA based on Relative Valuation is 250.2%.
The range of the Relative Valuation is 379.69 - 2,214.13 EUR.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 23.0x | 21.3x |
| Forward P/E multiples | 20.2x - 25.6x | 22.8x |
| Fair Price | 379.69 - 2,214.13 | 1,241.52 |
| Upside | 7.1% - 524.6% | 250.2% |
| Date | P/E |
| 2026-03-25 | 3.68 |
| 2026-03-24 | 3.62 |
| 2026-03-23 | 3.64 |
| 2026-03-20 | 3.65 |
| 2026-03-19 | 3.68 |
| 2026-03-18 | 3.66 |
| 2026-03-17 | 3.47 |
| 2026-03-16 | 3.41 |
| 2026-03-13 | 3.43 |
| 2026-03-12 | 3.47 |
| 2026-03-11 | 3.52 |
| 2026-03-10 | 3.56 |
| 2026-03-09 | 3.57 |
| 2026-03-06 | 3.59 |
| 2026-03-05 | 3.59 |
| 2026-03-04 | 3.62 |
| 2026-03-03 | 3.62 |
| 2026-03-02 | 3.74 |
| 2026-02-27 | 3.84 |
| 2026-02-26 | 3.77 |
| 2026-02-25 | 3.77 |
| 2026-02-24 | 3.83 |
| 2026-02-23 | 3.78 |
| 2026-02-20 | 3.82 |
| 2026-02-19 | 3.81 |
| 2026-02-18 | 3.81 |
| 2026-02-17 | 3.79 |
| 2026-02-16 | 3.73 |
| 2026-02-13 | 3.73 |
| 2026-02-12 | 3.71 |
| 2026-02-11 | 3.69 |
| 2026-02-10 | 3.71 |
| 2026-02-09 | 3.61 |
| 2026-02-06 | 3.63 |
| 2026-02-05 | 3.66 |
| 2026-02-04 | 3.66 |
| 2026-02-03 | 3.62 |
| 2026-02-02 | 3.64 |
| 2026-01-30 | 3.64 |
| 2026-01-29 | 3.71 |
| 2026-01-28 | 3.78 |
| 2026-01-27 | 3.82 |
| 2026-01-26 | 3.78 |
| 2026-01-23 | 3.77 |
| 2026-01-22 | 3.80 |
| 2026-01-21 | 3.72 |
| 2026-01-20 | 3.81 |
| 2026-01-19 | 3.62 |
| 2026-01-16 | 3.70 |
| 2026-01-15 | 3.73 |